Current through Register Vol. 63, No. 11, November 1, 2024
Section 332-026-0010 - Approved Legend Drugs For Maternal UseAn LDM may administer the following legend drugs as approved by the Board for maternal use:
(1) Anti-Hemorrhagics for use by intramuscular injection includes: (a) Synthetic Oxytocin (Pitocin, Syntocin and generic);(b) Methylergonovine (Methergine); or(c) Ergonovine (Ergotrate);(2) Anti-Hemorrhagics by intravenous infusion is limited to: (a) Synthetic Oxytocin (Pitocin, Syntocin, and generic); or(3) Anti-Hemorrhagics for oral administration is limited to: (a) Methylergonovine (Methergine);(b) Misoprostol (Cytotec).(4) Anti-Hemorrhagics for rectal administration is limited to Misoprostol (Cytotec).(5) Resuscitation is limited to medical oxygen and intravenous fluid replacement.(6) Intravenous fluid replacement includes: (a) Lactated Ringers Solution;(b) 0.9% Saline Solution;(c) D5LR (5% Dextrose in Lactated Ringers); or(d) D5W (5% Dextrose in water).(7) Anaphylactic treatment by subcutaneous injection is limited to Epinephrine.(8) Local anesthetic includes: (a) Lidocaine HCl (1% and 2%) (Xylocaine and generic);(c) Procaine HCl (Novocain, benzocaine, cetacane and generic); and(d) Sterile water papules.(9) Rhesus Sensitivity Prophylaxis is limited to Rho(d) Immune Globulin (RhoGAM, Gamulin Rh, Bay Rho-D and others).(10) Tissue adhesive (Dermabond or generic).(11) Intravenous antibiotics for Group B Streptococcal prophylaxis is limited to the following and is only to be used solely for the purpose of Group B Streptococcal prophylaxis:Or. Admin. Code § 332-026-0010
DEM 1-2001(Temp), f. & cert. ef. 10-1-01 thru 3-29-02; DEM 1-2002, f. 2-25-02 cert. ef. 3-1-02; DEM 1-2004, f. 6-29-04, cert. ef. 7-1-04; DEM 6-2010, f. 12-30-10, cert. ef. 1-1-11; DEM 1-2011(Temp), f. & cert. ef. 4-4-11 thru 9-27-11; Renumbered from 332-025-0040 by DEM 5-2011, f. & cert. ef. 9-26-11; DEM 2-2015, f. & cert. ef. 7/1/2015; DEM 3-2019, amend filed 12/19/2019, effective 1/1/2020; DEM 1-2023, amend filed 04/28/2023, effective 5/1/2023Statutory/Other Authority: ORS 676.615 & ORS 687.493
Statutes/Other Implemented: ORS 687.493